Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors

Seung Tae Kang, Eun Young Kim, Raghavendra Archary, Heejung Jung, Chi Hoon Park, Chang Soo Yun, Jong Yeon Hwang, Sang Un Choi, Chonghak Chae, Chong Ock Lee, Hyoung Rae Kim, Jae Du Ha, Dohyun Ryu, Sung Yun Cho

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

We report a series of phenyl substituted pyridazin-3-ones substituted with morpholino-pyrimidines. The SAR of the phenyl was explored and their c-Met kinase and cell-based inhibitory activity toward c-Met driven cell lines were evaluated. Described herein is a potent c-Met inhibitor by structural modification of the parent morpholino-pyridazinone scaffold, with particular focus on the phenyl and pyrimidine substituents.

Original languageEnglish
Pages (from-to)5093-5097
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number21
DOIs
StatePublished - 1 Nov 2014

Keywords

  • c-Met inhibitor
  • Cancer
  • Pyridazin-3-one

Fingerprint

Dive into the research topics of 'Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors'. Together they form a unique fingerprint.

Cite this